IP Library Granted Patent US 10,041,051
Granted Patent B2
US 10,041,051 · App. 15/432,080 · Granted Aug 7, 2018

Fusion polymerase and method for using the same

Inventors: Pei-Chung Hsieh (Topsfield, MA); Luo Sun (Hamilton, MA); Thomas C. Evans, Jr. (Topsfield, MA); Theodore B. Davis (Boxford, MA); Andrew Gardner (Manchester, MA)
Assignee: New England Biolabs, Inc.
C12N9/1252C12N9/20C12N9/22C12N9/96C12P19/34C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,041,051
App. No.
15/432,080
Granted
Aug 7, 2018
Kind
B2
Abstract

This disclosure provides, among other things, a composition comprising: comprising a fusion protein comprising: (a) a DNA polymerase; and (b) a heterologous sequence-specific DNA binding domain. A method for copying a DNA template, as well as a kit for performing the same, are also described.

Claims (39)

1. A method for producing a synthon, comprising:

(a) making a reaction mix comprising:

(i) a polymerase comprising:

an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:3;

an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:1; and

an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:2;

(ii) an exonuclease;

(iii) a ligase;

(iv) dNTPs; and

(v) a set of overlapping polynucleotides; and

(b) incubating the reaction mix under suitable reaction conditions to produce a synthon that contains sequence from each of the overlapping polynucleotides.

2. The method of claim 1 , wherein step (a) is done by adding a composition comprising the polymerase, exonuclease, ligase and dNTPs to a composition comprising the set of overlapping polynucleotides.

3. The method of claim 1 , wherein step (b) comprises incubating the reaction mix at temperature of at least 50° .

4. The method of claim 1 , wherein step (b) is an isothermal incubation.

5. The method of claim 1 , wherein step (b) comprises thermocycling.

6. The method of claim 1 , further comprising introducing the synthon of step (b) into a cell by transformation.

7. The method of claim 1 , further comprising amplifying the synthon of step (b) by polymerase chain reaction (PCR).

8. The method of claim 1 , wherein each of the overlapping polynucleotides is at a concentration in the range of 0.02 nM to 100 nM.

9. The method of claim 1 , wherein at least two of the oligonucleotides in the set have an overlap of at least 15 nucleotides.

10. The method of claim 1 , wherein the set of overlapping polynucleotides has at least two members.

11. The method of claim 1 , wherein the set of overlapping polynucleotides has at least five members.

12. The method of claim 1 , wherein the overlapping polynucleotides each has a length in the range of 100 bases to 30 kb.

13. The method of claim 1 , wherein the overlapping polynucleotides each has a length of at least 2 kb.

14. The method of claim 1 , wherein the set of overlapping polynucleotides overlapping polynucleotides comprises:

double-stranded polynucleotides;

at least one double strand polynucleotide and at least one single strand oligonucleotide;

single stranded oligonucleotides; and/or

a subpopulation of polynucleotides that are otherwise identical to one another except for a sequence that varies between the members of the sub-population.

15. The method of claim 1 , wherein the polymerase comprises:

(i) an amino acid sequence that has at least 95% sequence identity to SEQ ID NO:3,

(ii) an amino acid sequence that has at least 95% sequence identity to SEQ ID NO:1; and

(iii) an amino acid sequence that has at least 95% sequence identity to SEQ ID NO:2.

16. The method of claim 1 , wherein the polymerase comprises the amino acid sequence of SEQ ID NO:3.

17. The method of claim 1 , wherein the exonuclease is a 5′−3′ exonuclease.

18. The method of claim 1 , wherein the ligase is thermostable.

19. The method of claim 1 , wherein the reaction mix further comprises a single strand DNA binding protein.

20. The method of claim 1 , wherein the reaction mix does not comprise a crowding agent.

21. The method of claim 1 , wherein the reaction mix does not comprise a non strand-displacing polymerase.

22. The method of claim 1 , wherein the reaction mix comprises KCI at a concentration in the range of 7 mM to 150 mM.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2017
From: HSIEH, PEI-CHUNG; LUO, SUN; EVANS, THOMAS C., JR.; DAVIS, THEODORE B.; GARDNER, ANDREW
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 041735/0909 →
Continuity (6)
Continuation 15046166 · Feb 17, 2016
Continuation In Part 14837820 · Aug 27, 2015
Provisional Application 62193168 · Jul 16, 2015
Provisional Application 62189599 · Jul 7, 2015
Provisional Application 62042527 · Aug 27, 2014
Related Publication 20170152494A1 · Jun 1, 2017
Cited By (1)
US 12,410,429